Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
0.464
-0.028 (-5.63%)
At close: Nov 4, 2024, 4:00 PM
0.465
+0.001 (0.22%)
Pre-market: Nov 5, 2024, 4:51 AM EST
Enveric Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 3.5 | 2.29 | 17.72 | 17.36 | 1.58 | 0.04 | Upgrade
|
| Cash & Short-Term Investments | 3.5 | 2.29 | 17.72 | 17.36 | 1.58 | 0.04 | Upgrade
|
| Cash Growth | -50.54% | -87.09% | 2.12% | 999.55% | 3510.88% | -61.54% | Upgrade
|
| Other Receivables | 0.3 | 0.22 | - | - | - | - | Upgrade
|
| Receivables | 0.3 | 0.22 | - | - | - | - | Upgrade
|
| Prepaid Expenses | 0.71 | 0.26 | 0.55 | 0.38 | 0.7 | 0.07 | Upgrade
|
| Other Current Assets | 1 | 0.81 | 0.16 | - | - | - | Upgrade
|
| Total Current Assets | 5.52 | 3.58 | 18.43 | 17.74 | 2.28 | 0.11 | Upgrade
|
| Property, Plant & Equipment | 0.41 | 0.51 | 0.74 | 0.47 | - | - | Upgrade
|
| Goodwill | - | - | - | 1.59 | - | - | Upgrade
|
| Other Intangible Assets | 0.13 | 0.21 | 0.38 | 6.92 | 1.82 | - | Upgrade
|
| Total Assets | 6.05 | 4.3 | 19.55 | 26.72 | 4.1 | 0.11 | Upgrade
|
| Accounts Payable | 0.46 | 1.22 | 0.46 | 0.68 | 0.68 | 1.16 | Upgrade
|
| Accrued Expenses | 0.18 | 0.77 | 1.71 | 1.29 | - | - | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 0.74 | Upgrade
|
| Current Portion of Leases | - | - | 0.06 | 0.11 | - | - | Upgrade
|
| Other Current Liabilities | 0.01 | 0.35 | 1.76 | - | - | 0.02 | Upgrade
|
| Total Current Liabilities | 0.65 | 2.34 | 4 | 2.08 | 0.68 | 1.92 | Upgrade
|
| Long-Term Leases | - | - | - | 0.07 | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | 1.61 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0.65 | - | - | Upgrade
|
| Total Liabilities | 0.65 | 2.34 | 4 | 4.41 | 0.68 | 1.92 | Upgrade
|
| Common Stock | 0.08 | 0.03 | 0.02 | 0.01 | 0.1 | 0.05 | Upgrade
|
| Additional Paid-In Capital | 106.73 | 100.82 | 94.4 | 83.07 | 15.22 | 3.04 | Upgrade
|
| Retained Earnings | -100.84 | -96.5 | -79.21 | -60.74 | -11.76 | -4.89 | Upgrade
|
| Comprehensive Income & Other | -0.57 | -2.39 | -0.54 | -0.03 | -0.18 | -0.01 | Upgrade
|
| Total Common Equity | 5.41 | 1.96 | 14.67 | 22.31 | 3.38 | -1.81 | Upgrade
|
| Minority Interest | - | - | 0.89 | - | - | - | Upgrade
|
| Shareholders' Equity | 5.41 | 1.96 | 15.56 | 22.31 | 3.42 | -1.81 | Upgrade
|
| Total Liabilities & Equity | 6.05 | 4.3 | 19.55 | 26.72 | 4.1 | 0.11 | Upgrade
|
| Total Debt | - | - | 0.06 | 0.18 | - | 0.74 | Upgrade
|
| Net Cash (Debt) | 3.5 | 2.29 | 17.66 | 17.18 | 1.58 | -0.7 | Upgrade
|
| Net Cash Growth | -50.47% | -87.04% | 2.80% | 988.38% | - | - | Upgrade
|
| Net Cash Per Share | 0.87 | 1.06 | 12.21 | 36.37 | 13.72 | -6.59 | Upgrade
|
| Filing Date Shares Outstanding | 8.92 | 7.29 | 2.08 | 1.05 | 0.39 | 6.4 | Upgrade
|
| Total Common Shares Outstanding | 7.88 | 2.74 | 2.08 | 0.65 | 3.48 | 6.4 | Upgrade
|
| Working Capital | 4.87 | 1.24 | 14.44 | 15.65 | 1.6 | -1.81 | Upgrade
|
| Book Value Per Share | 0.69 | 0.71 | 7.06 | 34.23 | 0.97 | -0.28 | Upgrade
|
| Tangible Book Value | 5.28 | 1.75 | 14.29 | 13.79 | 1.57 | -1.81 | Upgrade
|
| Tangible Book Value Per Share | 0.67 | 0.64 | 6.88 | 21.17 | 0.45 | -0.28 | Upgrade
|
| Machinery | 0.84 | 0.87 | 0.86 | 0.32 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.